Stock Analysts’ Updated EPS Estimates for October 9th (AAPL, AAV, ALAB, ARHS, BAC, BDTX, BEP, BKD, DQ, GANX)

Stock Analysts’ updated eps estimates for Wednesday, October 9th:

Apple (NASDAQ:AAPL) had its neutral rating reiterated by analysts at Piper Sandler. The firm currently has a $225.00 target price on the stock.

Advantage Energy (TSE:AAV) (NYSE:AAV) had its buy rating reiterated by analysts at TD Securities. They currently have a C$13.00 price target on the stock.

Astera Labs (NASDAQ:ALAB) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $65.00 target price on the stock.

Arhaus (NASDAQ:ARHS) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $12.00 target price on the stock.

Bank of America (NYSE:BAC) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $46.00 price target on the stock.

Black Diamond Therapeutics (NASDAQ:BDTX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $11.00 target price on the stock.

Brookfield Renewable Partners (NYSE:BEP) (TSE:BEP) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $31.00 price target on the stock.

Brookdale Senior Living (NYSE:BKD) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $9.00 target price on the stock.

Daqo New Energy (NYSE:DQ) had its hold rating reaffirmed by analysts at Daiwa Capital Markets. The firm currently has a $25.00 target price on the stock, up from their previous target price of $18.00.

Gain Therapeutics (NASDAQ:GANX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $8.00 target price on the stock.

General Motors (NYSE:GM) (TSE:GMM.U) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $55.00 price target on the stock.

General Motors (NYSE:GM) (TSE:GMM.U) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $54.00 price target on the stock.

Humana (NYSE:HUM) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $250.00 target price on the stock.

MiNK Therapeutics (NASDAQ:INKT) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $9.00 target price on the stock.

Kroger (NYSE:KR) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $62.00 target price on the stock.

Inari Medical (NASDAQ:NARI) had its hold rating reissued by analysts at Needham & Company LLC.

Omnicell (NASDAQ:OMCL) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $48.00 target price on the stock.

The Pennant Group (NASDAQ:PNTG) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $40.00 target price on the stock.

Roblox (NYSE:RBLX) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $49.00 target price on the stock.

RCI Hospitality (NASDAQ:RICK) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $98.00 target price on the stock.

Sage Therapeutics (NASDAQ:SAGE) had its neutral rating reiterated by analysts at HC Wainwright. The firm currently has a $25.00 price target on the stock.

TriMas (NASDAQ:TRS) had its buy rating reaffirmed by analysts at BWS Financial. BWS Financial currently has a $40.00 target price on the stock.

U.S. Physical Therapy (NYSE:USPH) had its outperform rating reaffirmed by analysts at Barrington Research. The firm currently has a $108.00 target price on the stock.

Viking Therapeutics (NASDAQ:VKTX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $90.00 target price on the stock.

Virpax Pharmaceuticals (NASDAQ:VRPX) had its hold rating reaffirmed by analysts at Maxim Group.

VIZIO (NYSE:VZIO) had its hold rating reiterated by analysts at Needham & Company LLC.

Waldencast (NASDAQ:WALD) had its outperform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $6.00 price target on the stock.

Zeta Global (NYSE:ZETA) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $36.00 price target on the stock.

Zeta Global (NYSE:ZETA) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $34.00 price target on the stock.